MARKET

PRVB

PRVB

PROVENTION BIO, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.20
+0.55
+6.36%
After Hours: 9.96 +0.76 +8.26% 17:50 03/31 EDT
OPEN
8.69
PREV CLOSE
8.65
HIGH
10.00
LOW
8.68
VOLUME
1.29M
TURNOVER
--
52 WEEK HIGH
22.82
52 WEEK LOW
2.275
MARKET CAP
343.73M
P/E (TTM)
-8.5422
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PRVB stock price target is 23.90 with a high estimate of 30.00 and a low estimate of 18.50.

EPS

PRVB News

More
  • Cramer's lightning round: 'You do want to buy defense stocks right here'
  • CNBC.com · 1d ago
  • Provention Bio: Discounted Price, Insider Buying, And Catalysts Frame The Opportunity
  • Seeking Alpha - Article · 1d ago
  • Cramer's lightning round: 'I like Lockheed Martin very much'
  • CNBC.com · 4d ago
  • Cramer's lightning round: Buy Marvell Tech because '5G is king'
  • CNBC.com · 5d ago

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About PRVB

Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
More

Webull offers kinds of Provention Bio Inc stock information, including NASDAQ:PRVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRVB stock news, and many more online research tools to help you make informed decisions.